Literature DB >> 12883956

Myringitis bullosa haemorrhagica associated with meningo-encephalitis.

D C Wild1, P D R Spraggs.   

Abstract

An unusual case of a patient presenting with myringitis bullosa haemorrhagica (MBH), who subsequently developed acute otitis media and meningo-encephalitis, is described. The aetiology of MBH is discussed, and recommendations for the management of patients with acute otitis are made.

Entities:  

Mesh：

Year:  2003        PMID： 12883956     DOI： 10.1007/s00405-002-0577-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


  6 in total

1.  INFECTION WITH ARTIFICIALLY PROPAGATED EATON AGENT (MYCOPLASMA PNEUMONIAE). IMPLICATIONS FOR DEVELOPMENT OF ATTENUATED VACCINE FOR COLD AGGLUTININ-POSITIVE PNEUMONIA.

Authors:  R B COUCH; T R CATE; R M CHANOCK
Journal:  JAMA       Date:  1964-02-08       Impact factor: 56.272

2.  THE ETIOLOGICAL ROLE OF MYCOPLASMA PNEUMONIAE IN OTITIS MEDIA IN CHILDREN.

Authors:  O SOBESLAVSKY; M ABRAHAMOVIC
Journal:  Pediatrics       Date:  1965-04       Impact factor: 7.124

3.  Ear involvement (myringitis) and primary atypical pneumonia following inoculation of volunteers with Eaton agent.

Authors:  D RIFKIND; R CHANOCK; H KRAVETZ; K JOHNSON; V KNIGHT
Journal:  Am Rev Respir Dis       Date:  1962-04

Review 4.  Bullous myringitis: a review.

Authors:  J Marais; B A Dale
Journal:  Clin Otolaryngol Allied Sci       Date:  1997-12

5.  Acute otitis media in children. Bacteriological findings in middle ear fluid obtained by needle aspiration.

Authors:  M Feingold; J O Klein; G E Haslam; M Finland; S S Gellis; J G Tilles
Journal:  Am J Dis Child       Date:  1966-04

6.  Otitis media in the practice of pediatrics. Bacteriological and clinical observations.

Authors:  J D Coffey
Journal:  Pediatrics       Date:  1966-07       Impact factor: 7.124
  6 in total
  1 in total

Review 1.  Complications of acute otitis media in children.

Authors:  Kimmo Leskinen
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.